143 results on '"Kahn, Fredrik"'
Search Results
2. Correction: The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort
3. Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome
4. Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave – a nested case-control study among vaccinated adults in Sweden
5. Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months
6. Blood culture time to positivity in non-β-hemolytic streptococcal bacteremia as a predictor of infective endocarditis—a retrospective cohort study
7. The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort
8. Revival of ecological studies during the COVID-19 pandemic
9. Synovial fibroblasts from children with oligoarticular juvenile idiopathic arthritis induce migration and prolong viability of neutrophils.
10. Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions
11. Bacteremic sepsis leads to higher mortality when adjusting for confounders with propensity score matching
12. Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management—Reanalysis of Retrospective Bacteremia Cohorts
13. Repeated measures of Heparin-binding protein (HBP) and procalcitonin during septic shock: biomarker kinetics and association with cardiovascular organ dysfunction
14. Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment—a distinct inflammatory pattern for oligoarticular juvenile arthritis
15. Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis
16. Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency Department
17. A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa
18. Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?
19. Immune evasiveness of SARS-CoV-2 variants and vaccine selection.
20. Secreted Group IIA Phospholipase A₂ Protects Humans Against the Group B Streptococcus: Experimental and Clinical Evidence
21. Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions.
22. Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis
23. Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis
24. Primary diphtheria immunisation of adolescents and adults with low‐dose vaccine, a survey of historic evidence from the literature.
25. Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis
26. The Dynamics of Circulating Heparin-Binding Protein: Implications for Its Use as a Biomarker.
27. Ascorbic acid attenuates activation and cytokine production in sepsis‐like monocytes.
28. Time to Blood Culture Positivity: An Independent Predictor of Mortality in Streptococcus Pyogenes Bacteremia.
29. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022.
30. Carotid Plaque Morphology is Similar in Patients with Reduced and Normal Renal Function
31. Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.
32. Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022.
33. High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population – first results from a cohort study in Southern Sweden.
34. Surveillance of COVID-19 vaccine effectiveness: a real-time case–control study in southern Sweden.
35. Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis: authors' reply
36. High risk of coronary artery aneurysm in Kawasaki disease.
37. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine: COMMENT from Gruel et al.: RESPONSE from Kahn et al.
38. Suggested treatment of serious complications to COVID‐19 vaccination with IdeS, a bacterial antibody‐cleaving enzyme
39. Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID‐19.
40. Scores for sepsis detection and risk stratification – construction of a novel score using a statistical approach and validation of RETTS.
41. Streptococcus pyogenes - a manipulator of human defences
42. One Scoring System Does Not Fit All Healthcare Settings.
43. Antibodies against a Surface Protein of Streptococcus pyogenes Promote a Pathological Inflammatory Response.
44. Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.
45. NEWS2 Is Superior to qSOFA in Detecting Sepsis with Organ Dysfunction in the Emergency Department.
46. Penicillin-resistant Streptococcus pyogenes?
47. Functional and Structural Properties of a Novel Protein and Virulence Factor (Protein sHIP) in Streptococcus pyogenes.
48. Treatment outcome with penicillin G or cloxacillin in penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective cohort study.
49. Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis.
50. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.